Chinese medicine research programme confirmed a success by Brussels

The Directors of Global Regulatory Services(GRS) were directly involved in the €1.1m European Union (EU) research project examining Good Practice in Traditional Chinese Medicine Research (GP-TCM) in the Post-Genomic Era. "I'm delighted, and very proud, that our involvement has contributed to such a positive outcome," said Bobby Deal, Managing Director.

Greer Deal was the Deputy Coordinator of The Seventh Work Package (Commercial R&D) of the FP7 EU-China GP-TCM Consortium.  Both Directors were very actively involved in The Seventh Work Package (WP7). 

The aim of WP7 was:  "to establish a collaborative network towards formulating an easy-to-follow statement on the various regulatory frameworks for botanicals, emphasising the synergies and highlighting the differences, in order to contribute to the long term goal of global harmonisation."

 Bobby Deal said: "It was a challenge not only because of the complexities of Traditional Chinese Medicines but also the logistics of bringing together people from all over the world to share their knowledge and experiences of TCMs in both traditional and modern settings. 

"We've learnt a lot along the way and have also made some wonderful friends.  It's fantastic to have the work of the GP-TCM recognised and for this to be ongoing in the form of the GP-TCM Research Association".

___________________________________________





Read more

Looking for something specific?